Multinational pharmaceutical companies, such as Norvatis, begun to take an action to raise distribution cost

It is observed that multinational pharmaceutical companies are reviewingraises of pharmaceutical distribution cost on distribution companies.

According to a person in the Korea Pharmaceutical Distribution Association (KPDA), it is known that a number of multinational pharmaceutical companies, such as Norvatis Korea, which has rejected to raise pharmaceutical distribution cost, are reviewing di...